Human antibodies made in cows could be developed to treat MERS [Reuters (UK)]
Leidos Holdings, Inc. (LDOS)
Last leidos holdings, inc. earnings: 2/18 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.leidos.com
Company Research
Source: Reuters
Human antibodies made in cows could be developed to treat MERS | Reuters 3 Min Read LONDON (Reuters) - Human antibodies made in genetically engineered cows have proved safe in an early stage clinical trial, U.S. scientists said on Wednesday, and could be developed into a treatment for the fatal viral disease, MERS. MERS, or Middle East Respiratory Syndrome, is a SARS-like viral infection first identified in Saudi Arabia in 2012 that has caused deadly outbreaks in the Middle East as well as sporadic cases around the world. Despite more than five years of waves of infection, no effective treatment or vaccine has been developed against MERS, which has a 35 percent case fatality rate and has so far killed at least 740 people worldwide. More than 80 percent of MERS cases have been reported in Saudi Arabia, according to the World Health Organization. In research published in the Lancet Infectious Diseases journal on Wednesday, scientists found that human antibodies called SAB-301 generated
Show less
Read more
Impact Snapshot
Event Time:
LDOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LDOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LDOS alerts
High impacting Leidos Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LDOS
News
- Leidos (LDOS) Reports Next Week: Wall Street Expects Earnings Growth [Yahoo! Finance]Yahoo! Finance
- Tria Federal Announces Larry Bradshaw as New Chief Financial OfficerPR Web
- Wall Street Analysts See Leidos (LDOS) as a Buy: Should You Invest? [Yahoo! Finance]Yahoo! Finance
- Leidos (LDOS) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Leidos Holdings, Inc. (NYSE: LDOS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
LDOS
Earnings
- 2/13/24 - Beat
LDOS
Sec Filings
- 4/1/24 - Form 3
- 4/1/24 - Form 4
- 4/1/24 - Form 4
- LDOS's page on the SEC website